The effect of atypical antipsychotic medications in individuals with anorexia nervosa

A systematic review and meta-analysis

Jocelyn Lebow, Leslie A. Sim, Patricia J. Erwin, M. Hassan Murad

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Objective: Given that atypical antipsychotic medications have been increasingly prescribed for improving weight gain in anorexia nervosa (AN), we conducted a systematic review and meta-analyses to estimate the influence of atypical antipsychotics on BMI, eating disorder, and psychiatric symptoms in individuals with AN. Method: Independent reviewers selected studies and extracted study characteristics, methodologic quality, and outcomes for the intention-to-treat group from randomized clinical trials comparing the effect of atypical antipsychotic use to placebo or an active control treatment on BMI. Results: Compared with placebo, atypical antipsychotics were associated with a nonsignificant increase in BMI (weighted mean difference, WMD = 0.18, 95% CI: -0.36, 0.72; I2 = 26%) and a nonsignificant effect on the drive for thinness and body dissatisfaction. Compared with placebo or active control, these medications led to an increase in anxiety and overall eating disorder symptoms. However, there was a significant reduction over placebo or active control on level of depression. © 2012 by Wiley Periodicals, Inc. (Int J Eat Disord 2013)

Original languageEnglish (US)
Pages (from-to)332-339
Number of pages8
JournalInternational Journal of Eating Disorders
Volume46
Issue number4
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

Anorexia Nervosa
Antipsychotic Agents
Meta-Analysis
Placebos
Thinness
Weight Gain
Psychiatry
Anxiety
Randomized Controlled Trials
Depression
Feeding and Eating Disorders
Therapeutics

Keywords

  • anorexia nervosa
  • atypical antipsychotic
  • meta-analyses

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

The effect of atypical antipsychotic medications in individuals with anorexia nervosa : A systematic review and meta-analysis. / Lebow, Jocelyn; Sim, Leslie A.; Erwin, Patricia J.; Murad, M. Hassan.

In: International Journal of Eating Disorders, Vol. 46, No. 4, 05.2013, p. 332-339.

Research output: Contribution to journalArticle

Lebow, Jocelyn ; Sim, Leslie A. ; Erwin, Patricia J. ; Murad, M. Hassan. / The effect of atypical antipsychotic medications in individuals with anorexia nervosa : A systematic review and meta-analysis. In: International Journal of Eating Disorders. 2013 ; Vol. 46, No. 4. pp. 332-339.
@article{a1ba981fa58649499489f82154611edb,
title = "The effect of atypical antipsychotic medications in individuals with anorexia nervosa: A systematic review and meta-analysis",
abstract = "Objective: Given that atypical antipsychotic medications have been increasingly prescribed for improving weight gain in anorexia nervosa (AN), we conducted a systematic review and meta-analyses to estimate the influence of atypical antipsychotics on BMI, eating disorder, and psychiatric symptoms in individuals with AN. Method: Independent reviewers selected studies and extracted study characteristics, methodologic quality, and outcomes for the intention-to-treat group from randomized clinical trials comparing the effect of atypical antipsychotic use to placebo or an active control treatment on BMI. Results: Compared with placebo, atypical antipsychotics were associated with a nonsignificant increase in BMI (weighted mean difference, WMD = 0.18, 95{\%} CI: -0.36, 0.72; I2 = 26{\%}) and a nonsignificant effect on the drive for thinness and body dissatisfaction. Compared with placebo or active control, these medications led to an increase in anxiety and overall eating disorder symptoms. However, there was a significant reduction over placebo or active control on level of depression. {\circledC} 2012 by Wiley Periodicals, Inc. (Int J Eat Disord 2013)",
keywords = "anorexia nervosa, atypical antipsychotic, meta-analyses",
author = "Jocelyn Lebow and Sim, {Leslie A.} and Erwin, {Patricia J.} and Murad, {M. Hassan}",
year = "2013",
month = "5",
doi = "10.1002/eat.22059",
language = "English (US)",
volume = "46",
pages = "332--339",
journal = "International Journal of Eating Disorders",
issn = "0276-3478",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - The effect of atypical antipsychotic medications in individuals with anorexia nervosa

T2 - A systematic review and meta-analysis

AU - Lebow, Jocelyn

AU - Sim, Leslie A.

AU - Erwin, Patricia J.

AU - Murad, M. Hassan

PY - 2013/5

Y1 - 2013/5

N2 - Objective: Given that atypical antipsychotic medications have been increasingly prescribed for improving weight gain in anorexia nervosa (AN), we conducted a systematic review and meta-analyses to estimate the influence of atypical antipsychotics on BMI, eating disorder, and psychiatric symptoms in individuals with AN. Method: Independent reviewers selected studies and extracted study characteristics, methodologic quality, and outcomes for the intention-to-treat group from randomized clinical trials comparing the effect of atypical antipsychotic use to placebo or an active control treatment on BMI. Results: Compared with placebo, atypical antipsychotics were associated with a nonsignificant increase in BMI (weighted mean difference, WMD = 0.18, 95% CI: -0.36, 0.72; I2 = 26%) and a nonsignificant effect on the drive for thinness and body dissatisfaction. Compared with placebo or active control, these medications led to an increase in anxiety and overall eating disorder symptoms. However, there was a significant reduction over placebo or active control on level of depression. © 2012 by Wiley Periodicals, Inc. (Int J Eat Disord 2013)

AB - Objective: Given that atypical antipsychotic medications have been increasingly prescribed for improving weight gain in anorexia nervosa (AN), we conducted a systematic review and meta-analyses to estimate the influence of atypical antipsychotics on BMI, eating disorder, and psychiatric symptoms in individuals with AN. Method: Independent reviewers selected studies and extracted study characteristics, methodologic quality, and outcomes for the intention-to-treat group from randomized clinical trials comparing the effect of atypical antipsychotic use to placebo or an active control treatment on BMI. Results: Compared with placebo, atypical antipsychotics were associated with a nonsignificant increase in BMI (weighted mean difference, WMD = 0.18, 95% CI: -0.36, 0.72; I2 = 26%) and a nonsignificant effect on the drive for thinness and body dissatisfaction. Compared with placebo or active control, these medications led to an increase in anxiety and overall eating disorder symptoms. However, there was a significant reduction over placebo or active control on level of depression. © 2012 by Wiley Periodicals, Inc. (Int J Eat Disord 2013)

KW - anorexia nervosa

KW - atypical antipsychotic

KW - meta-analyses

UR - http://www.scopus.com/inward/record.url?scp=84876033997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876033997&partnerID=8YFLogxK

U2 - 10.1002/eat.22059

DO - 10.1002/eat.22059

M3 - Article

VL - 46

SP - 332

EP - 339

JO - International Journal of Eating Disorders

JF - International Journal of Eating Disorders

SN - 0276-3478

IS - 4

ER -